| Entry | |
|---|
| Name | Dopexamine (USAN/INN) |
|---|
| Formula | C22H32N2O2
|
|---|
| Exact mass | 356.2464
|
|---|
| Mol weight | 356.50
|
|---|
| Structure | 
|
|---|
| Simcomp | |
|---|
| Class | Cardiovascular agent
DG01703 Cardiotonic
DG01699 Catecholamine cardiotonic
DG01456 Adrenergic receptor agonist
DG01455 beta-Adrenergic receptor agonist
DG01452 beta2-Adrenergic receptor agonist
DG01951 Catecholamine adrenergic receptor agonist
Neuropsychiatric agent
DG01472 Dopamine agonist
|
|---|
| Remark | |
|---|
| Efficacy | Cardiotonic, beta-Adrenergic receptor agonist, Dopamine receptor agonist |
|---|
| Comment | Dopamine derivative
|
|---|
| Target | |
|---|
| Pathway | | hsa04080 | Neuroactive ligand-receptor interaction |
| hsa04261 | Adrenergic signaling in cardiomyocytes |
|
|---|
| Interaction | |
|---|
| Brite | Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
C CARDIOVASCULAR SYSTEM
C01 CARDIAC THERAPY
C01C CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES
C01CA Adrenergic and dopaminergic agents
C01CA14 Dopexamine
D03891 Dopexamine (USAN/INN)
Drug groups [BR:br08330]
Cardiovascular agent
DG01703 Cardiotonic
DG01699 Catecholamine cardiotonic
DG00222 Dopexamine
D03891 Dopexamine
DG01456 Adrenergic receptor agonist
DG01455 beta-Adrenergic receptor agonist
DG01452 beta2-Adrenergic receptor agonist
DG00222 Dopexamine
D03891 Dopexamine
DG01951 Catecholamine adrenergic receptor agonist
DG00222 Dopexamine
D03891 Dopexamine
Neuropsychiatric agent
DG01472 Dopamine agonist
DG00222 Dopexamine
D03891 Dopexamine
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Adrenaline
ADRB2
D03891 Dopexamine (USAN/INN)
Dopamine
DRD
D03891 Dopexamine (USAN/INN)
Drug groups [BR:br08330]
Cardiovascular agent
DG01703 Cardiotonic
DG01699 Catecholamine cardiotonic
DG00222 Dopexamine
DG01456 Adrenergic receptor agonist
DG01455 beta-Adrenergic receptor agonist
DG01452 beta2-Adrenergic receptor agonist
DG00222 Dopexamine
DG01951 Catecholamine adrenergic receptor agonist
DG00222 Dopexamine
Neuropsychiatric agent
DG01472 Dopamine agonist
DG00222 Dopexamine
|
|---|
| Other DBs | |
|---|
| LinkDB | |
|---|
| KCF data |
ATOM 26
1 C8y C 8.9600 -16.5200
2 C8y C 8.9600 -17.9200
3 C8x C 10.2200 -18.6200
4 C8x C 11.4100 -17.9200
5 C8y C 11.4100 -16.5200
6 C8x C 10.2200 -15.8200
7 O1a O 7.7700 -15.8200
8 O1a O 7.7700 -18.6200
9 C1b C 12.6700 -15.8200
10 C1b C 13.8600 -16.5200
11 N1b N 15.0500 -15.8200
12 C1b C 16.2400 -16.5200
13 C1b C 17.5000 -15.8200
14 C1b C 18.6900 -16.5200
15 C1b C 19.8800 -15.8200
16 C1b C 21.0700 -16.5200
17 C1b C 22.2600 -15.8200
18 N1b N 23.4500 -16.5200
19 C1b C 24.6400 -15.8200
20 C1b C 25.9700 -16.5200
21 C8y C 27.1600 -15.8200
22 C8x C 28.3500 -16.5200
23 C8x C 29.5400 -15.8200
24 C8x C 29.5400 -14.4200
25 C8x C 28.3500 -13.7200
26 C8x C 27.1600 -14.4200
BOND 27
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 1 7 1
8 2 8 1
9 5 9 1
10 9 10 1
11 10 11 1
12 11 12 1
13 12 13 1
14 13 14 1
15 14 15 1
16 15 16 1
17 16 17 1
18 17 18 1
19 18 19 1
20 19 20 1
21 20 21 1
22 21 22 2
23 22 23 1
24 23 24 2
25 24 25 1
26 25 26 2
27 21 26 1
|
|---|
